Statistics
Publications
2
Citations
40
H-Index
2
Active since
1978
Affiliations
Fox Chase Cancer Center(Current)
Comis Rl is an author at Fox Chase Cancer Center specializing in hematologic malignancy therapy, dose-limiting toxicity assessment, and immunomodulatory drug therapy.
Publications per year
1978–1989
2
2
Phase I and preliminary phase II study of neocarzinostatin.
Griffin Tw, Comis Rl, Lokich Jj et al. · PubMed · 1978 · 10 citations
Medicine, Oncology, Pharmacology +16
1–2 of 2